Form 8-K - Current report:
SEC Accession No. 0001193125-24-084756
Filing Date
2024-04-02
Accepted
2024-04-02 16:10:55
Documents
13
Period of Report
2024-04-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d818590d8k.htm   iXBRL 8-K 21546
  Complete submission text file 0001193125-24-084756.txt   146556

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA maia-20240401.xsd EX-101.SCH 2880
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20240401_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20240401_pre.xml EX-101.PRE 11727
16 EXTRACTED XBRL INSTANCE DOCUMENT d818590d8k_htm.xml XML 3744
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 24814300
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)